CUSIP: 45250K107
Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
31,775,586
-
Share change
-
+642,591
-
Total reported value
-
$478,244,453
-
Price per share
-
$15.05
-
Number of holders
-
64
-
Value change
-
+$9,838,953
-
Number of buys
-
31
-
Number of sells
-
23
Quarterly Holders Quick Answers
What is CUSIP 45250K107?
CUSIP 45250K107 identifies IMGO - IMAGO BIOSCIENCES INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2022
-
Previous quarter:
Q2 2022
Recent filing periods for CUSIP 45250K107:
Institutional Holders of IMAGO BIOSCIENCES INC - COM (IMGO) as of Q3 2022
As of 30 Sep 2022,
IMAGO BIOSCIENCES INC - COM (IMGO) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,775,586 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., Omega Fund Management, LLC, Frazier Life Sciences Management, L.P., FARALLON CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, Blackstone Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, and EMERALD ADVISERS, LLC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.